Microcarrier-Based Cell Culture Is Fastest Growing Segment Fueling The Growth Of Cell Culture Market
 |
| Cell Culture Market |
The
global cell culture market is estimated to be valued at US$ 10.89 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market Overview:
Cell culture involves growing cells in a controlled nutritious environment
outside their natural environment. Cell culture finds wide application in areas
such as biotechnology, pharmaceuticals, toxicology testing, and regenerative
medicine. The growing demand for monoclonal antibodies, recombinant proteins,
stem cells, and vaccine production is increasing the need for cell culture
technologies.
Market key trends:
One of the key trends in the cell culture market is the increasing adoption of
single-use bioreactor systems. These systems offer advantages such as reduced
complexity and labor requirement for cleaning and sterilization as compared to
stainless steel bioreactors. In addition, single-use bioreactors reduce the
risk of product cross-contamination. The disposable nature of the system also
lowers the downtime between batches as preparation and cleaning is not
required. This helps improve production efficiency and lower overall capital
costs.
Segment Analysis
The global Cell Culture
Market is segmented into
consumables and equipment. Consumables dominated the market accounting for over
65% share in 2023. Within consumables, medium dominated the segment owing to
higher utilization of cell culture medium for various cell-based research activities.
Equipment segment consists of bioreactors, cell culture vessels, centrifuges,
biosafety cabinets, and other supporting equipment. Bioreactors segment is
expected to grow at fastest pace over the forecast period due to increasing
demand for continuous cell culture process for commercial production of
biopharmaceuticals and advancement in microcarrier technology.
Key Takeaways
The global cell culture market is expected to witness high growth, exhibiting CAGR of 7.2% over the forecast period,
due to increasing demand for cell-based research for developing
biopharmaceuticals, growing stem cell research, and rising prevalence of
chronic and infectious diseases.
Regional analysis North America dominated the global cell culture market in
2023 owing to presence of leading biopharmaceutical companies, rising stem cell
research, and strong government support for R&D activities in the region.
Asia Pacific is expected to grow at fastest pace during the forecast period due
to increasing government initiatives, improving healthcare infrastructure, and
growing biotechnology industry.
Key players operating in the cell culture market are Corning Incorporated,
Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo
Fisher Scientific Inc., VWR International LLC, and Lonza. Corning Incorporated
holds leading position globally owing to wide product portfolio including cell
culture media, bioprocess container systems, and related equipment. Merck KGaA
dominates the upstream and downstream bio production market with comprehensive
offering across the bioproduction workflow.
Comments
Post a Comment